Immune cell activity in tumor microenvironment

Immune cell activity in the "tumor microenvironment" refers to the collective actions and interactions of various innate and adaptive immune cells—such as macrophages, neutrophils, natural killer cells, dendritic cells, T lymphocytes, and B lymphocytes—within the complex environment surrounding tumor cells. These activities can be either anti-tumorigenic (e.g., cytotoxicity against cancer) or pro-tumorigenic (e.g., immunosuppression that facilitates tumor growth). The balance between these opposing roles is shaped by cytokines like interleukin‑4 (IL‑4) and interferon-gamma (IFN‑γ), which influence differentiation states such as "M1/M2 macrophages". While targeting elements of this system has led to major advances in cancer immunotherapy—including checkpoint inhibitors like "anti-PD-(L)1/CTLA4 antibodies"—the term itself does not refer to a discrete molecular target but rather an aggregate biological process involving multiple cellular players. The phrase "Immune cell activity in tumor microenvironment" is not a canonical molecular target but describes a broad functional phenomenon involving many different molecules and pathways. It cannot be mapped directly onto standard drug discovery targets such as receptors or enzymes.

Other names

Tumor immune microenvironmentTIMEImmune cell infiltration in tumor microenvironmentImmune landscape of TME